Table 2.
Control Group (n = 15) | Sleeve Gastrectomy Group (n = 20) | |||||
---|---|---|---|---|---|---|
Sphingolipids (μg/ml) | Preop | Po Day 1 | Po Day 30 | Preop | Po Day 1 | Po Day 30 |
16:0 SM (d18:1/16:0) | 217,16 ± 19,10 | 225,40 ± 27,36 | 267,25 ± 24,50 | 279,88 ± 19,43a | 223,68 ± 20,34b,c | 262,14 ± 17,85 |
18:0 SM (d18:1/18:0) | 100,24 ± 9,67 | 113,84 ± 13,51 | 103,51 ± 14,02 | 131,97 ± 11,91a | 126,93 ± 11,10 | 154,90 ± 9,83d |
24:0 SM (d18:1/24:0) | 75,94 ± 7,19 | 88,93 ± 12,62 | 113,06 ± 9,16e | 98,64 ± 10,59 | 60,57 ± 8,14f | 58,54 ± 6,84f,d |
Values are mean ± SEM. Preop, preoperation; Po, postoperation. 16:0 SM (d18:1/16:0), N-palmitoyl-D-erythrosphingosylphosphorylcholine; 18:0 SM (d18:1/18:0), N-stearoyl-D-erythro-sphingosylphosphorylcholine; 24:0 SM (d18:1/24:0), N-lignoceroyl-D-erythro-sphingosylphosphorylcholine
a, p < 0,05 vs. control Preop. Statistical analysis was done by t-test
b, p = 0,015 vs. sleeve gastrectomy Preop. Statistical analysis was done by paired t-test
c, p = 0,006 vs. sleeve gastrectomy Po day 30. Statistical analysis was done by paired t-test
d, p < 0,01 vs. control Po day 30. Statistical analysis was done by t-test
e, p < 0,001 vs. control Preop. Statistical analysis was done by paired t-test
f, p < 0,001 vs. sleeve gastrectomy Preop. Statistical analysis was done by paired t-test